Logo image of 1EXPE.MI

EXPEDIA GROUP INC (1EXPE.MI) Stock Fundamental Analysis

BIT:1EXPE - Euronext Milan - US30212P3038 - Common Stock - Currency: EUR

188.4  -4.98 (-2.58%)

Fundamental Rating

5

Taking everything into account, 1EXPE scores 5 out of 10 in our fundamental rating. 1EXPE was compared to 55 industry peers in the Hotels, Restaurants & Leisure industry. 1EXPE scores excellent on profitability, but there are concerns on its financial health. 1EXPE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

1EXPE had positive earnings in the past year.
In the past year 1EXPE had a positive cash flow from operations.
In multiple years 1EXPE reported negative net income over the last 5 years.
Of the past 5 years 1EXPE 4 years had a positive operating cash flow.
1EXPE.MI Yearly Net Income VS EBIT VS OCF VS FCF1EXPE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

1EXPE has a Return On Assets of 5.49%. This is in the better half of the industry: 1EXPE outperforms 69.09% of its industry peers.
1EXPE has a better Return On Equity (78.87%) than 96.36% of its industry peers.
1EXPE has a better Return On Invested Capital (13.93%) than 78.18% of its industry peers.
1EXPE had an Average Return On Invested Capital over the past 3 years of 10.99%. This is in line with the industry average of 11.33%.
The 3 year average ROIC (10.99%) for 1EXPE is below the current ROIC(13.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.49%
ROE 78.87%
ROIC 13.93%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
1EXPE.MI Yearly ROA, ROE, ROIC1EXPE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

1EXPE has a better Profit Margin (8.97%) than 63.64% of its industry peers.
In the last couple of years the Profit Margin of 1EXPE has grown nicely.
The Operating Margin of 1EXPE (12.15%) is comparable to the rest of the industry.
1EXPE's Operating Margin has improved in the last couple of years.
1EXPE's Gross Margin of 89.44% is amongst the best of the industry. 1EXPE outperforms 89.09% of its industry peers.
1EXPE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.15%
PM (TTM) 8.97%
GM 89.44%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
1EXPE.MI Yearly Profit, Operating, Gross Margins1EXPE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1EXPE is creating some value.
1EXPE has less shares outstanding than it did 1 year ago.
1EXPE has less shares outstanding than it did 5 years ago.
The debt/assets ratio for 1EXPE has been reduced compared to a year ago.
1EXPE.MI Yearly Shares Outstanding1EXPE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1EXPE.MI Yearly Total Debt VS Total Assets1EXPE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

1EXPE has an Altman-Z score of 1.45. This is a bad value and indicates that 1EXPE is not financially healthy and even has some risk of bankruptcy.
1EXPE's Altman-Z score of 1.45 is in line compared to the rest of the industry. 1EXPE outperforms 49.09% of its industry peers.
1EXPE has a debt to FCF ratio of 2.69. This is a good value and a sign of high solvency as 1EXPE would need 2.69 years to pay back of all of its debts.
1EXPE has a better Debt to FCF ratio (2.69) than 76.36% of its industry peers.
A Debt/Equity ratio of 3.35 is on the high side and indicates that 1EXPE has dependencies on debt financing.
The Debt to Equity ratio of 1EXPE (3.35) is worse than 61.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.35
Debt/FCF 2.69
Altman-Z 1.45
ROIC/WACC1.68
WACC8.31%
1EXPE.MI Yearly LT Debt VS Equity VS FCF1EXPE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.72 indicates that 1EXPE may have some problems paying its short term obligations.
With a Current ratio value of 0.72, 1EXPE is not doing good in the industry: 65.45% of the companies in the same industry are doing better.
1EXPE has a Quick Ratio of 0.72. This is a bad value and indicates that 1EXPE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of 1EXPE (0.72) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
1EXPE.MI Yearly Current Assets VS Current Liabilites1EXPE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

1EXPE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.64%, which is quite impressive.
Measured over the past years, 1EXPE shows a quite strong growth in Earnings Per Share. The EPS has been growing by 14.87% on average per year.
1EXPE shows a small growth in Revenue. In the last year, the Revenue has grown by 6.64%.
1EXPE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.56% yearly.
EPS 1Y (TTM)24.64%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%38.95%
Revenue 1Y (TTM)6.64%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%10.29%

3.2 Future

The Earnings Per Share is expected to grow by 16.71% on average over the next years. This is quite good.
The Revenue is expected to grow by 6.45% on average over the next years.
EPS Next Y18.93%
EPS Next 2Y18.99%
EPS Next 3Y17.5%
EPS Next 5Y16.71%
Revenue Next Year6.61%
Revenue Next 2Y6.83%
Revenue Next 3Y7.06%
Revenue Next 5Y6.45%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
1EXPE.MI Yearly Revenue VS Estimates1EXPE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
1EXPE.MI Yearly EPS VS Estimates1EXPE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.76 indicates a correct valuation of 1EXPE.
76.36% of the companies in the same industry are more expensive than 1EXPE, based on the Price/Earnings ratio.
1EXPE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.09, 1EXPE is valued correctly.
1EXPE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1EXPE is cheaper than 74.55% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.90. 1EXPE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 16.76
Fwd PE 14.09
1EXPE.MI Price Earnings VS Forward Price Earnings1EXPE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

1EXPE's Enterprise Value to EBITDA is on the same level as the industry average.
Based on the Price/Free Cash Flow ratio, 1EXPE is valued a bit cheaper than 69.09% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.35
EV/EBITDA 11.16
1EXPE.MI Per share data1EXPE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of 1EXPE may justify a higher PE ratio.
A more expensive valuation may be justified as 1EXPE's earnings are expected to grow with 17.50% in the coming years.
PEG (NY)0.89
PEG (5Y)1.13
EPS Next 2Y18.99%
EPS Next 3Y17.5%

2

5. Dividend

5.1 Amount

1EXPE has a Yearly Dividend Yield of 1.02%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.33, 1EXPE pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, 1EXPE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.02%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DP0%
EPS Next 2Y18.99%
EPS Next 3Y17.5%
1EXPE.MI Yearly Income VS Free CF VS Dividend1EXPE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

EXPEDIA GROUP INC

BIT:1EXPE (3/3/2025, 7:00:00 PM)

188.4

-4.98 (-2.58%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-06 2025-02-06/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners97.28%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap24.28B
Analysts72.56
Price Target205.47 (9.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.02%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.08%
Min EPS beat(2)-0.95%
Max EPS beat(2)15.12%
EPS beat(4)3
Avg EPS beat(4)53.42%
Min EPS beat(4)-0.95%
Max EPS beat(4)187.08%
EPS beat(8)6
Avg EPS beat(8)-17.83%
EPS beat(12)8
Avg EPS beat(12)-10.27%
EPS beat(16)11
Avg EPS beat(16)-1.1%
Revenue beat(2)1
Avg Revenue beat(2)-0.78%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)1.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)1.66%
Revenue beat(8)2
Avg Revenue beat(8)-0.98%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)0.33%
PT rev (1m)8%
PT rev (3m)33.1%
EPS NQ rev (1m)88.97%
EPS NQ rev (3m)702.93%
EPS NY rev (1m)0.98%
EPS NY rev (3m)-7.29%
Revenue NQ rev (1m)-1.75%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-1.22%
Revenue NY rev (3m)-5.14%
Valuation
Industry RankSector Rank
PE 16.76
Fwd PE 14.09
P/S 1.93
P/FCF 11.35
P/OCF 8.57
P/B 16.98
P/tB N/A
EV/EBITDA 11.16
EPS(TTM)11.24
EY5.97%
EPS(NY)13.37
Fwd EY7.1%
FCF(TTM)16.6
FCFY8.81%
OCF(TTM)21.99
OCFY11.67%
SpS97.57
BVpS11.1
TBVpS-43.5
PEG (NY)0.89
PEG (5Y)1.13
Profitability
Industry RankSector Rank
ROA 5.49%
ROE 78.87%
ROCE 18.96%
ROIC 13.93%
ROICexc 28.48%
ROICexgc N/A
OM 12.15%
PM (TTM) 8.97%
GM 89.44%
FCFM 17.01%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
ROICexc(3y)20.29%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y125.83%
ROICexc growth 5Y22.57%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
F-Score8
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 3.35
Debt/FCF 2.69
Debt/EBITDA 2.09
Cap/Depr 90.21%
Cap/Sales 5.52%
Interest Coverage 7.2
Cash Conversion 123.3%
Profit Quality 189.66%
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z 1.45
F-Score8
WACC8.31%
ROIC/WACC1.68
Cap/Depr(3y)92.88%
Cap/Depr(5y)87.19%
Cap/Sales(3y)5.93%
Cap/Sales(5y)8.19%
Profit Quality(3y)403.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.64%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%38.95%
EPS Next Y18.93%
EPS Next 2Y18.99%
EPS Next 3Y17.5%
EPS Next 5Y16.71%
Revenue 1Y (TTM)6.64%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%10.29%
Revenue Next Year6.61%
Revenue Next 2Y6.83%
Revenue Next 3Y7.06%
Revenue Next 5Y6.45%
EBIT growth 1Y13.43%
EBIT growth 3Y85.19%
EBIT growth 5Y11.61%
EBIT Next Year133.26%
EBIT Next 3Y40.4%
EBIT Next 5Y26.87%
FCF growth 1Y26.3%
FCF growth 3Y-8.85%
FCF growth 5Y7.7%
OCF growth 1Y14.68%
OCF growth 3Y-6.28%
OCF growth 5Y2.2%